AST 0 3 0 3 B-clinical_variable
and 4 7 4 7 O
ALT 8 11 8 11 B-clinical_variable
< 12 13 12 13 O
/=2.0 13 18 13 18 O
x 19 20 19 20 I-upper_bound
ULN 21 24 21 24 I-upper_bound

Age 0 3 25 28 B-age
18 4 6 29 31 B-lower_bound
years 7 12 32 37 I-lower_bound
or 13 15 38 40 O
older 16 21 41 46 O

Any 0 3 47 50 O
major 4 9 51 56 B-treatment
surgery 10 17 57 64 I-treatment
, 17 18 64 65 O
radiotherapy 19 31 66 78 B-treatment
, 31 32 78 79 O
chemotherapy 33 45 80 92 B-treatment
, 45 46 92 93 O
biologic 47 55 94 102 B-treatment
therapy 56 63 103 110 I-treatment
, 63 64 110 111 O
immunotherapy 65 78 112 125 B-treatment
, 78 79 125 126 O
experimental 80 92 127 139 B-treatment
therapy 93 100 140 147 I-treatment
within 101 107 148 154 O
2 108 109 155 156 B-upper_bound
weeks 110 115 157 162 I-upper_bound
prior 116 121 163 168 I-upper_bound
to 122 124 169 171 O
the 125 128 172 175 O
first 129 134 176 181 B-treatment
dose 135 139 182 186 I-treatment
of 140 142 187 189 I-treatment
the 143 146 190 193 I-treatment
study 147 152 194 199 I-treatment
drugs 153 158 200 205 I-treatment

Current 0 7 206 213 B-treatment
therapy 8 15 214 221 I-treatment
with 16 20 222 226 O
other 21 26 227 232 O
systemic 27 35 233 241 B-treatment
anti 36 40 242 246 I-treatment
- 40 41 246 247 I-treatment
neoplastic 41 51 247 257 I-treatment
or 52 54 258 260 O
anti 55 59 261 265 B-treatment
- 59 60 265 266 I-treatment
neoplastic 60 70 266 276 I-treatment
investigational 71 86 277 292 I-treatment
agents 87 93 293 299 I-treatment

ECOG 0 4 300 304 B-clinical_variable
performance 5 16 305 316 I-clinical_variable
status 17 23 317 323 I-clinical_variable
< 24 25 324 325 O
/=2 25 28 325 328 O

Females 0 7 329 336 B-gender
of 8 10 337 339 O
childbearing 11 23 340 352 O
potential 24 33 353 362 O
must 34 38 363 367 O
have 39 43 368 372 O
a 44 45 373 374 O
negative 46 54 375 383 B-pregnancy
serum 55 60 384 389 I-pregnancy
or 61 63 390 392 I-pregnancy
urine 64 69 393 398 I-pregnancy
beta 70 74 399 403 I-pregnancy
human 75 80 404 409 I-pregnancy
chorionic 81 90 410 419 I-pregnancy
gonadotrophin 91 104 420 433 I-pregnancy
( 105 106 434 435 I-pregnancy
beta 106 110 435 439 I-pregnancy
- 110 111 439 440 I-pregnancy
hCG 111 114 440 443 I-pregnancy
) 114 115 443 444 I-pregnancy
pregnancy 116 125 445 454 I-pregnancy
test 126 130 455 459 O
result 131 137 460 466 O
within 138 144 467 473 O
24 145 147 474 476 B-upper_bound
hours 148 153 477 482 I-upper_bound
prior 154 159 483 488 I-upper_bound
to 160 162 489 491 O
the 163 166 492 495 O
first 167 172 496 501 O
dose 173 177 502 506 O
of 178 180 507 509 O
treatment 181 190 510 519 B-treatment
and 191 194 520 523 O
must 195 199 524 528 O
agree 200 205 529 534 B-contraception_consent
to 206 208 535 537 I-contraception_consent
use 209 212 538 541 I-contraception_consent
an 213 215 542 544 I-contraception_consent
effective 216 225 545 554 I-contraception_consent
contraception 226 239 555 568 I-contraception_consent
method 240 246 569 575 I-contraception_consent
to 247 249 576 578 O
avoid 250 255 579 584 O
pregnancy 256 265 585 594 O
for 266 269 595 598 O
23 270 272 599 601 B-upper_bound
weeks 273 278 602 607 I-upper_bound
( 279 280 608 609 O
30 280 282 609 611 O
days 283 287 612 616 O
plus 288 292 617 621 O
the 293 296 622 625 O
time 297 301 626 630 O
required 302 310 631 639 O
for 311 314 640 643 O
nivolumab 315 324 644 653 B-treatment
to 325 327 654 656 O
undergo 328 335 657 664 O
five 336 340 665 669 O
half 341 345 670 674 O
- 345 346 674 675 O
lives 346 351 675 680 O
) 351 352 680 681 O
after 353 358 682 687 O
the 359 362 688 691 O
last 363 367 692 696 O
dose 368 372 697 701 O
of 373 375 702 704 O
investigational 376 391 705 720 B-treatment
drugs 392 397 721 726 I-treatment

Females 0 7 727 734 B-gender
of 8 10 735 737 O
non- 11 15 738 742 O
childbearing 16 28 743 755 O
potential 29 38 756 765 O
are 39 42 766 769 O
those 43 48 770 775 O
who 49 52 776 779 O
are 53 56 780 783 O
postmenopausal 57 71 784 798 O
greater 72 79 799 806 O
than 80 84 807 811 O
1 85 86 812 813 B-lower_bound
year 87 91 814 818 I-lower_bound
or 92 94 819 821 O
who 95 98 822 825 O
have 99 103 826 830 O
had 104 107 831 834 O
a 108 109 835 836 O
bilateral 110 119 837 846 O
tubal 120 125 847 852 O
ligation 126 134 853 861 O
or 135 137 862 864 O
hysterectomy 138 150 865 877 O

Females 0 7 878 885 B-gender
who 8 11 886 889 O
are 12 15 890 893 O
pregnant 16 24 894 902 B-pregnancy
or 25 27 903 905 O
lactating 28 37 906 915 O

For 0 3 916 919 O
hypomethylating 4 19 920 935 B-chronic_disease
failure 20 27 936 943 O
cohorts 28 35 944 951 O
only 36 40 952 956 O
, 40 41 956 957 O
more 42 46 958 962 O
than 47 51 963 967 O
4 52 53 968 969 B-lower_bound
months 54 60 970 976 I-lower_bound
since 61 66 977 982 O
last 67 71 983 987 O
cycle 72 77 988 993 O
of 78 80 994 996 O
HMA 81 84 997 1000 B-clinical_variable

For 0 3 1001 1004 O
hypomethylating 4 19 1005 1020 O
failure 20 27 1021 1028 O
cohorts 28 35 1029 1036 O
, 35 36 1036 1037 O
treatment 37 46 1038 1047 B-treatment
for 47 50 1048 1051 O
MDS 51 54 1052 1055 B-chronic_disease
with 55 59 1056 1060 O
any 60 63 1061 1064 O
other 64 69 1065 1070 O
drug 70 74 1071 1075 O
not 75 78 1076 1079 O
being 79 84 1080 1085 O
an 85 87 1086 1088 O
HMA 88 91 1089 1092 O
with 92 96 1093 1097 O
the 97 100 1098 1101 O
following 101 110 1102 1111 O
exceptions 111 121 1112 1122 O

History 0 7 1123 1130 O
of 8 10 1131 1133 O
another 11 18 1134 1141 O
primary 19 26 1142 1149 O
invasive 27 35 1150 1158 B-cancer
malignancy 36 46 1159 1169 I-cancer
unless 47 53 1170 1176 O
definitively 54 66 1177 1189 O
treated 67 74 1190 1197 O
or 75 77 1198 1200 O
unless 78 84 1201 1207 O
in 85 87 1208 1210 O
remission 88 97 1211 1220 O
for 98 101 1221 1224 O
at 102 104 1225 1227 O
least 105 110 1228 1233 O
2 111 112 1234 1235 B-lower_bound
years 113 118 1236 1241 I-lower_bound
. 118 119 1241 1242 O
Patients 120 128 1243 1251 O
with 129 133 1252 1256 O
non 134 137 1257 1260 B-cancer
- 137 138 1260 1261 I-cancer
melanoma 138 146 1261 1269 I-cancer
skin 147 151 1270 1274 I-cancer
cancers 152 159 1275 1282 I-cancer
or 160 162 1283 1285 O
with 163 167 1286 1290 O
carcinomas 168 178 1291 1301 B-cancer
in 179 181 1302 1304 I-cancer
situ 182 186 1305 1309 I-cancer
are 187 190 1310 1313 O
eligible 191 199 1314 1322 O
regardless 200 210 1323 1333 O
of 211 213 1334 1336 O
the 214 217 1337 1340 O
time 218 222 1341 1345 O
from 223 227 1346 1350 O
diagnosis 228 237 1351 1360 O
( 238 239 1361 1362 O
including 239 248 1362 1371 O
concomitant 249 260 1372 1383 O
diagnoses 261 270 1384 1393 O
) 270 271 1393 1394 O

History 0 7 1395 1402 O
of 8 10 1403 1405 O
pneumonitis 11 22 1406 1417 B-chronic_disease

Males 0 5 1418 1423 B-gender
who 6 9 1424 1427 O
have 10 14 1428 1432 O
partners 15 23 1433 1441 O
of 24 26 1442 1444 O
childbearing 27 39 1445 1457 O
potential 40 49 1458 1467 O
must 50 54 1468 1472 O
agree 55 60 1473 1478 B-contraception_consent
to 61 63 1479 1481 I-contraception_consent
use 64 67 1482 1485 I-contraception_consent
an 68 70 1486 1488 I-contraception_consent
effective 71 80 1489 1498 I-contraception_consent
contraceptive 81 94 1499 1512 I-contraception_consent
method 95 101 1513 1519 O
during 102 108 1520 1526 O
the 109 112 1527 1530 O
study 113 118 1531 1536 O
and 119 122 1537 1540 O
a 123 124 1541 1542 O
period 125 131 1543 1549 O
of 132 134 1550 1552 O
31 135 137 1553 1555 B-upper_bound
weeks 138 143 1556 1561 I-upper_bound
after 144 149 1562 1567 I-upper_bound
the 150 153 1568 1571 O
last 154 158 1572 1576 B-treatment
dose 159 163 1577 1581 I-treatment
of 164 166 1582 1584 I-treatment
investigational 167 182 1585 1600 I-treatment
drug 183 187 1601 1605 I-treatment

No 0 2 1606 1608 O
response 3 11 1609 1617 O
will 12 16 1618 1622 O
be 17 19 1623 1625 O
lack 20 24 1626 1630 O
of 25 27 1631 1633 O
clinical 28 36 1634 1642 O
benefit 37 44 1643 1650 O
after 45 50 1651 1656 O
at 51 53 1657 1659 O
least 54 59 1660 1665 O
6 60 61 1666 1667 B-lower_bound
cycles 62 68 1668 1674 O
of 69 71 1675 1677 O
HMA 72 75 1678 1681 B-treatment
therapy 76 83 1682 1689 I-treatment

Patients 0 8 1690 1698 O
known 9 14 1699 1704 O
to 15 17 1705 1707 O
be 18 20 1708 1710 O
positive 21 29 1711 1719 O
for 30 33 1720 1723 O
hepatitis 34 43 1724 1733 B-chronic_disease
B 44 45 1734 1735 I-chronic_disease
surface 46 53 1736 1743 O
antigen 54 61 1744 1751 O
expression 62 72 1752 1762 O
or 73 75 1763 1765 O
with 76 80 1766 1770 O
active 81 87 1771 1777 O
hepatitis 88 97 1778 1787 B-chronic_disease
C 98 99 1788 1789 I-chronic_disease
infection 100 109 1790 1799 I-chronic_disease
( 110 111 1800 1801 O
positive 111 119 1801 1809 O
by 120 122 1810 1812 O
polymerase 123 133 1813 1823 O
chain 134 139 1824 1829 O
reaction 140 148 1830 1838 O
or 149 151 1839 1841 O
on 152 154 1842 1844 O
antiviral 155 164 1845 1854 B-treatment
therapy 165 172 1855 1862 I-treatment
for 173 176 1863 1866 O
hepatitis 177 186 1867 1876 O
C 187 188 1877 1878 O
within 189 195 1879 1885 O
the 196 199 1886 1889 O
last 200 204 1890 1894 B-upper_bound
6 205 206 1895 1896 I-upper_bound
months 207 213 1897 1903 I-upper_bound
) 213 214 1903 1904 O

Patients 0 8 1905 1913 O
need 9 13 1914 1918 O
to 14 16 1919 1921 O
have 17 21 1922 1926 O
relapsed 22 30 1927 1935 O
or 31 33 1936 1938 O
progressed 34 44 1939 1949 O
after 45 50 1950 1955 O
any 51 54 1956 1959 O
number 55 61 1960 1966 O
of 62 64 1967 1969 O
cycles 65 71 1970 1976 O
of 72 74 1977 1979 O
HMA 75 78 1980 1983 B-treatment
therapy 79 86 1984 1991 I-treatment

Patients 0 8 1992 2000 O
that 9 13 2001 2005 O
do 14 16 2006 2008 O
not 17 20 2009 2012 O
respond 21 28 2013 2020 O
to 29 31 2021 2023 O
HMA 32 35 2024 2027 B-treatment
therapy 36 43 2028 2035 I-treatment
will 44 48 2036 2040 O
also 49 53 2041 2045 O
be 54 56 2046 2048 O
allowed 57 64 2049 2056 O
in 65 67 2057 2059 O
the 68 71 2060 2063 O
study 72 77 2064 2069 O

Patients 0 8 2070 2078 O
who 9 12 2079 2082 O
are 13 16 2083 2086 O
on 17 19 2087 2089 O
high 20 24 2090 2094 O
dose 25 29 2095 2099 O
steroid 30 37 2100 2107 B-treatment
( 38 39 2108 2109 O
equivalent 39 49 2109 2119 O
of 50 52 2120 2122 O
prednisone 53 63 2123 2133 B-treatment
more 64 68 2134 2138 O
than 69 73 2139 2143 O
10 74 76 2144 2146 B-lower_bound
mg 77 79 2147 2149 I-lower_bound
a 80 81 2150 2151 O
day 82 85 2152 2155 O
) 85 86 2155 2156 O
or 87 89 2157 2159 O
immune 90 96 2160 2166 B-treatment
suppression 97 108 2167 2178 I-treatment
medications 109 120 2179 2190 I-treatment

Patients 0 8 2191 2199 O
with 9 13 2200 2204 O
MDS 14 17 2205 2208 B-cancer
( 18 19 2209 2210 O
up 19 21 2210 2212 O
to 22 24 2213 2215 O
20 25 27 2216 2218 B-upper_bound
% 27 28 2218 2219 I-upper_bound
blasts 29 35 2220 2226 I-upper_bound
) 35 36 2226 2227 O
of 37 39 2228 2230 O
any 40 43 2231 2234 O
risk 44 48 2235 2239 O
as 49 51 2240 2242 O
defined 52 59 2243 2250 O
as 60 62 2251 2253 O

Patients 0 8 2254 2262 O
with 9 13 2263 2267 O
a 14 15 2268 2269 O
history 16 23 2270 2277 O
of 24 26 2278 2280 O
Inflammatory 27 39 2281 2293 B-chronic_disease
Bowel 40 45 2294 2299 I-chronic_disease
Disease 46 53 2300 2307 I-chronic_disease
such 54 58 2308 2312 O
as 59 61 2313 2315 O
Crohn 62 67 2316 2321 B-chronic_disease
's 67 69 2321 2323 I-chronic_disease
disease 70 77 2324 2331 I-chronic_disease
and 78 81 2332 2335 O
ulcerative 82 92 2336 2346 B-chronic_disease
colitis 93 100 2347 2354 I-chronic_disease

Patients 0 8 2355 2363 O
with 9 13 2364 2368 O
any 14 17 2369 2372 O
other 18 23 2373 2378 O
known 24 29 2379 2384 O
concurrent 30 40 2385 2395 O
severe 41 47 2396 2402 O
and/or 48 54 2403 2409 O
uncontrolled 55 67 2410 2422 O
medical 68 75 2423 2430 O
condition 76 85 2431 2440 O
( 86 87 2441 2442 O
e.g. 87 91 2442 2446 O
uncontrolled 92 104 2447 2459 B-chronic_disease
diabetes 105 113 2460 2468 I-chronic_disease
; 113 114 2468 2469 O
cardiovascular 115 129 2470 2484 B-chronic_disease
disease 130 137 2485 2492 I-chronic_disease
including 138 147 2493 2502 O
congestive 148 158 2503 2513 B-chronic_disease
heart 159 164 2514 2519 I-chronic_disease
failure 165 172 2520 2527 I-chronic_disease
NYHA 173 177 2528 2532 B-clinical_variable
Class 178 183 2533 2538 I-clinical_variable
III 184 187 2539 2542 B-lower_bound
or 188 190 2543 2545 O
IV 191 193 2546 2548 B-upper_bound
, 193 194 2548 2549 O
myocardial 195 205 2550 2560 B-chronic_disease
infarction 206 216 2561 2571 I-chronic_disease
within 217 223 2572 2578 O
6 224 225 2579 2580 B-upper_bound
months 226 232 2581 2587 I-upper_bound
, 232 233 2587 2588 O
and 234 237 2589 2592 O
poorly 238 244 2593 2599 O
controlled 245 255 2600 2610 B-chronic_disease
hypertension 256 268 2611 2623 I-chronic_disease
; 268 269 2623 2624 O
chronic 270 277 2625 2632 B-chronic_disease
renal 278 283 2633 2638 I-chronic_disease
failure 284 291 2639 2646 I-chronic_disease
; 291 292 2646 2647 O
or 293 295 2648 2650 O
active 296 302 2651 2657 B-chronic_disease
uncontrolled 303 315 2658 2670 I-chronic_disease
infection 316 325 2671 2680 I-chronic_disease
) 325 326 2680 2681 O
which 327 332 2682 2687 O
, 332 333 2687 2688 O
in 334 336 2689 2691 O
the 337 340 2692 2695 O
opinion 341 348 2696 2703 O
of 349 351 2704 2706 O
the 352 355 2707 2710 O
investigator 356 368 2711 2723 O
could 369 374 2724 2729 O
compromise 375 385 2730 2740 O
participation 386 399 2741 2754 O
in 400 402 2755 2757 O
the 403 406 2758 2761 O
study 407 412 2762 2767 O

Patients 0 8 2768 2776 O
with 9 13 2777 2781 O
autoimmune 14 24 2782 2792 B-chronic_disease
diseases 25 33 2793 2801 I-chronic_disease
( 34 35 2802 2803 O
e.g. 35 39 2803 2807 O
, 39 40 2807 2808 O
rheumatoid 41 51 2809 2819 B-chronic_disease
arthritis 52 61 2820 2829 I-chronic_disease
, 61 62 2829 2830 O
systemic 63 71 2831 2839 O
progressive 72 83 2840 2851 O
sclerosis 84 93 2852 2861 B-chronic_disease
[ 94 95 2862 2863 O
scleroderma 95 106 2863 2874 B-chronic_disease
] 106 107 2874 2875 O
, 107 108 2875 2876 O
Systemic 109 117 2877 2885 B-chronic_disease
Lupus 118 123 2886 2891 I-chronic_disease
Erythematosus 124 137 2892 2905 I-chronic_disease
, 137 138 2905 2906 O
autoimmune 139 149 2907 2917 O
vasculitis 150 160 2918 2928 B-chronic_disease
[ 161 162 2929 2930 O
e.g. 162 166 2930 2934 O
, 166 167 2934 2935 O
Wegener 168 175 2936 2943 B-chronic_disease
's 175 177 2943 2945 I-chronic_disease
Granulomatosis 178 192 2946 2960 I-chronic_disease
] 192 193 2960 2961 I-chronic_disease
) 193 194 2961 2962 O

Patients 0 8 2963 2971 O
with 9 13 2972 2976 O
history 14 21 2977 2984 O
of 22 24 2985 2987 O
HIV 25 28 2988 2991 B-chronic_disease
disease 29 36 2992 2999 I-chronic_disease
are 37 40 3000 3003 O
also 41 45 3004 3008 O
excluded 46 54 3009 3017 O
from 55 59 3018 3022 O
the 60 63 3023 3026 O
study 64 69 3027 3032 O

Previously 0 10 3033 3043 O
treated 11 18 3044 3051 O
with 19 23 3052 3056 O
HMA 24 27 3057 3060 B-treatment
agent 28 33 3061 3066 I-treatment

Prior 0 5 3067 3072 B-treatment
treatment 6 15 3073 3082 I-treatment
with 16 20 3083 3087 I-treatment
allogeneic 21 31 3088 3098 I-treatment
stem 32 36 3099 3103 I-treatment
cell 37 41 3104 3108 I-treatment
transplantation 42 57 3109 3124 I-treatment

Prior 0 5 3125 3130 O
treatment 6 15 3131 3140 B-treatment
with 16 20 3141 3145 I-treatment
growth 21 27 3146 3152 I-treatment
factors 28 35 3153 3160 I-treatment
and/or 36 42 3161 3167 O
lenalidomide 43 55 3168 3180 B-treatment
is 56 58 3181 3183 O
allowed 59 66 3184 3191 O
for 67 70 3192 3195 O
any 71 74 3196 3199 O
cohort 75 81 3200 3206 O

creatinine 0 10 3207 3217 B-clinical_variable
< 11 12 3218 3219 O
/=2.0 12 17 3219 3224 O
x 18 19 3225 3226 I-upper_bound
ULN 20 23 3227 3230 I-upper_bound

serum 0 5 3231 3236 B-clinical_variable
bilirubin 6 15 3237 3246 I-clinical_variable
< 16 17 3247 3248 O
/=2.0 17 22 3248 3253 O
x 23 24 3254 3255 I-upper_bound
ULN 25 28 3256 3259 I-upper_bound

